Transgene S.A.
TRGNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $155 | $149 | $1 | $244 |
| - Cash | $17 | $16 | $4 | $6 |
| + Debt | $10 | $1 | $2 | $4 |
| Enterprise Value | $149 | $134 | -$1 | $242 |
| Revenue | $6 | $8 | $3 | $10 |
| % Growth | -19.6% | 152.7% | -68.7% | – |
| Gross Profit | -$28 | -$22 | -$29 | -$23 |
| % Margin | -439.6% | -274.5% | -929% | -229.1% |
| EBITDA | -$27 | -$28 | -$30 | -$24 |
| % Margin | -419.5% | -360% | -970.2% | -235.7% |
| Net Income | -$34 | -$22 | -$33 | -$20 |
| % Margin | -534.7% | -282.6% | -1,049.6% | -200.2% |
| EPS Diluted | -0.34 | -0.22 | -0.33 | -0.22 |
| % Growth | -54.5% | 33.3% | -50% | – |
| Operating Cash Flow | -$24 | -$35 | -$20 | -$32 |
| Capital Expenditures | -$3 | -$3 | -$2 | -$1 |
| Free Cash Flow | -$27 | -$37 | -$22 | -$33 |